APOA4 and Increased total eosinophil count: Treatment with ApoA‐IV for 8 days protected mice from airway eosinophilia as reflected by a ~42% reduction in eosinophil counts in the BAL fluid of ApoA‐IV‐treated mice compared to vehicle‐treated controls (Figure 4C).